Chihunt Wong

2.6k total citations
16 papers, 1.0k citations indexed

About

Chihunt Wong is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Chihunt Wong has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Chihunt Wong's work include Glycosylation and Glycoproteins Research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Genetics, Aging, and Longevity in Model Organisms (4 papers). Chihunt Wong is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Genetics, Aging, and Longevity in Model Organisms (4 papers). Chihunt Wong collaborates with scholars based in United States, Australia and Canada. Chihunt Wong's co-authors include D. Leanne Jones, M. Sar, Zhongxiang Zhou, Elizabeth M. Wilson, Lei Wang, Catherine J. McLeod, Abby F. Dernburg, Carolyn M. Phillips, Peter M. Carlton and Philip Meneely and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Chihunt Wong

16 papers receiving 997 citations

Peers

Countries citing papers authored by Chihunt Wong

Since Specialization

Citations

This map shows the geographic impact of Chihunt Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chihunt Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chihunt Wong more than expected).

Fields of papers citing papers by Chihunt Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chihunt Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chihunt Wong. The network helps show where Chihunt Wong may publish in the future.

Co-authorship network of co-authors of Chihunt Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Chihunt Wong. A scholar is included among the top collaborators of Chihunt Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chihunt Wong. Chihunt Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Cevostamab in Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I Study Demonstrate Clinically Meaningful Activity and Manageable Safety and Inform the Doses and Regimen for Combination Studies 2024 ·Blood ·Joshua Richter, Sheeba K. Thomas, (unknown), Jacob P. Laubach, Adam D. Cohen, Suzanne Trudel, Luciano J. Costa, Nizar J. Bahlis, Peter A. Forsberg, Rayan Kaedbey, Rafaël Fonseca, Andrew Spencer, Paula Rodríguez‐Otero, María‐Victoria Mateos, Chihunt Wong, James Cooper, Tulika Tyagi, Rin Nakamura, Voleak Choeurng, Alexander M. Lesokhin	8
2	P946: TOCILIZUMAB PRE-TREATMENT SIGNIFICANTLY REDUCES THE INCIDENCE OF CYTOKINE RELEASE SYNDROME IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE CEVOSTAMAB 2023 ·HemaSphere ·María‐Victoria Mateos, Nizar J. Bahlis, Andrew Spencer, Rayan Kaedbey, Paula Rodríguez‐Otero, Simon J. Harrison, Chihunt Wong, Grant K. Goodman, Rin Nakamura, Voleak Choeurng, James Fenimore Cooper, Suzanne Trudel	4
3	Pretreatment with Tocilizumab Prior to the CD3 Bispecific Cevostamab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Showed a Marked Reduction in Cytokine Release Syndrome Incidence and Severity 2022 ·Blood ·Suzanne Trudel, Nizar J. Bahlis, Andrew Spencer, Rayan Kaedbey, Paula Rodríguez‐Otero, Simon J. Harrison, Chihunt Wong, Grant R. Goodman, Rin Nakamura, Voleak Choeurng, James Fenimore Cooper, María‐Victoria Mateos	27
4	P-012: Cevostamab is efficacious and well tolerated in patients aged < 65 and ≥65 years with relapsed/refractory multiple myeloma (RRMM) 2022 ·Clinical Lymphoma Myeloma & Leukemia ·Amrita Krishnan, (unknown), Suzanne Trudel, Andrew Spencer, Alexander M. Lesokhin, Chihunt Wong, Voleak Choeurng, James Fenimore Cooper, Teiko Sumiyoshi, Grant K. Goodman, Hyun Yong Jin, (unknown), Simon J. Harrison	1
5	PROCLAIM-001: A first-in-human trial to assess tolerability of the protease-activatable anti-PD-L1 Probody CX-072 in solid tumors and lymphomas. 2017 ·Journal of Clinical Oncology ·Alexander I. Spira, Mark R. Middleton, Aung Naing, Karen A. Autio, John Nemunaitis, Johanna C. Bendell, Michael S. Gordon, Rachel Humphrey, Chihunt Wong, Naiyer A. Rizvi	2
6	Abstract A081: A PD-L1-targeted Probody provides antitumor efficacy while minimizing induction of systemic autoimmunity 2016 ·Cancer Immunology Research ·Chihunt Wong, Mei Li, Kenneth Wong, (unknown), Olga Vasiljeva, Jennifer Richardson, James W. West, Michael Kavanaugh, Bryan Irving	7
7	Abstract 2665: Transforming Notch ligands into tumor-antigen targets: A Probody-Drug Conjugate (PDC) targeting Jagged 1 and Jagged 2 2014 ·Cancer Research ·Jason Sagert, Jim West, Chihunt Wong, Luc Desnoyers, Olga Vasiljeva, Jennifer Richardson, Krishna R. Polu, Henry B. Lowman	6
8	Abstract C158: Tumor-specific inhibition of jagged-dependent notch signaling using a Probody™ therapeutic. 2013 ·Molecular Cancer Therapeutics ·Jason Sagert, James W. West, Olga Vasiljeva, Jennifer Richardson, Luc Desnoyers, Shouchun Liu, Annie Yang, Chihunt Wong, (unknown), Krishna R. Polu, Henry B. Lowman	3
9	Efficiency of Spermatogonial Dedifferentiation during Aging 2012 ·PLoS ONE ·Chihunt Wong, D. Leanne Jones	12
10	Direct visualization of Bcl-2 family protein interactions using live cell fluorescent protein redistribution assays 2012 ·Cell Death and Disease ·Chihunt Wong, Daniel J. Anderson, Erinna F. Lee, W. Douglas Fairlie, Mary J. C. Ludlam	10
11	Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells 2012 ·Blood ·Delphine Mérino, Seong Lin Khaw, Stefan Glaser, Daniel J. Anderson, Lisa D. Belmont, Chihunt Wong, Peng Yue, Mikara Robati, Belinda Phipson, W. Douglas Fairlie, Erinna F. Lee, Kirsteen J. Campbell, Cassandra J. Vandenberg, Suzanne Cory, Andrew W. Roberts, Mary J. C. Ludlam, David C.S. Huang, Philippe Bouillet	160
12	Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy 2011 ·Annals of Oncology ·Benjamin Chuah, Thomas C. Putti, Manuel Salto‐Tellez, Amanda Charlton, Philip Iau, Shaik Ahmad Buhari, Chihunt Wong, Sing‐Huang Tan, Andrea Li Ann Wong, Ching Wan Chan, Brian C. Goh, (unknown)	19
13	Stem Cell Dynamics in Response to Nutrient Availability 2010 ·Current Biology ·Catherine J. McLeod, Lei Wang, Chihunt Wong, D. Leanne Jones	143
14	Decline in Self-Renewal Factors Contributes to Aging of the Stem Cell Niche in the Drosophila Testis 2007 ·Cell stem cell ·(unknown), Chihunt Wong, (unknown), D. Leanne Jones	204
15	HIM-8 Binds to the X Chromosome Pairing Center and Mediates Chromosome-Specific Meiotic Synapsis 2005 ·Cell ·Carolyn M. Phillips, Chihunt Wong, Needhi Bhalla, Peter M. Carlton, (unknown), Philip Meneely, Abby F. Dernburg	227
16	Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains. 1993 ·Journal of Biological Chemistry ·Chihunt Wong, Zhongxiang Zhou, M. Sar, Elizabeth M. Wilson	176

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact